(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.41%) $924.25
(0.32%) $0.935
(0.80%) $11.04
(0.13%) $0.800
(-0.32%) $91.87
Live Chart Being Loaded With Signals
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide...
Stats | |
---|---|
Today's Volume | 1.02M |
Average Volume | 650 237 |
Market Cap | 0.00 |
EPS | $0 ( 2021-08-02 ) |
Last Dividend | $0.100 ( 2021-06-16 ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.188 (0.51%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-07-14 | Ogunro Edward A | Sell | 10 760 | Common Stock |
2021-07-14 | Ogunro Edward A | Sell | 50 133 | Common Stock |
2021-07-14 | Mcnamara Kevin M | Sell | 24 443 | Common Stock |
2021-07-14 | Mcnamara Kevin M | Sell | 75 925 | Common Stock |
2021-07-14 | Erickson Thomas W | Sell | 79 204 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 100 transactions |
Buy: 1 457 367 | Sell: 3 933 642 |
Volume Correlation
Luminex Corporation Correlation
10 Most Positive Correlations | |
---|---|
DSPG | 0.935 |
CCRC | 0.923 |
TVTY | 0.893 |
STAY | 0.893 |
IQ | 0.89 |
AUGX | 0.887 |
PUCK | 0.882 |
ACAH | 0.882 |
SKYX | 0.875 |
CROX | 0.875 |
10 Most Negative Correlations | |
---|---|
ODT | -0.927 |
TCDA | -0.921 |
XPDI | -0.911 |
EYEG | -0.91 |
ENPH | -0.901 |
GRAY | -0.895 |
LHDX | -0.89 |
LGHL | -0.879 |
HECCU | -0.879 |
MTEX | -0.877 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Luminex Corporation Correlation - Currency/Commodity
Luminex Corporation Financials
Annual | 2020 |
Revenue: | $417.40M |
Gross Profit: | $247.85M (59.38 %) |
EPS: | $0.336 |
FY | 2020 |
Revenue: | $417.40M |
Gross Profit: | $247.85M (59.38 %) |
EPS: | $0.336 |
FY | 2019 |
Revenue: | $334.64M |
Gross Profit: | $182.74M (54.61 %) |
EPS: | $-0.0900 |
FY | 2018 |
Revenue: | $315.82M |
Gross Profit: | $195.49M (61.90 %) |
EPS: | $0.420 |
Financial Reports:
No articles found.
Luminex Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0600 | 2017-03-22 |
Last Dividend | $0.100 | 2021-06-16 |
Next Dividend | $0 | N/A |
Payout Date | 2021-07-08 | |
Next Payout Date | N/A | |
# dividends | 18 | -- |
Total Paid Out | $1.350 | -- |
Avg. Dividend % Per Year | 0.22% | -- |
Score | 4.61 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.83 | |
Div. Directional Score | 9.48 | -- |
Year | Amount | Yield |
---|---|---|
2017 | $0.240 | 1.18% |
2018 | $0.240 | 1.18% |
2019 | $0.300 | 1.32% |
2020 | $0.370 | 1.61% |
2021 | $0.200 | 0.82% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0363 | 1.500 | 9.27 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0197 | 1.200 | 9.34 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0309 | 1.500 | -0.768 | -1.152 | [0.1 - 1] |
payoutRatioTTM | 1.087 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 5.82 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.30 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.54 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.271 | -1.500 | 5.48 | -8.21 | [0 - 0.6] |
interestCoverageTTM | 3.56 | 1.000 | 9.79 | 9.79 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.090 | 2.00 | 9.64 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.699 | 2.00 | 9.65 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.404 | -1.500 | 8.38 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.594 | 1.000 | 3.44 | 3.44 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.102 | 1.000 | 9.97 | 9.97 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.239 | 1.000 | 9.78 | 9.78 | [0.2 - 2] |
assetTurnoverTTM | 0.542 | 0.800 | 9.72 | 7.78 | [0.5 - 2] |
Total Score | 13.13 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 111.73 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0309 | 2.50 | -0.494 | -1.152 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.699 | 2.00 | 9.77 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.090 | 2.00 | 9.64 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.087 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0.552 | 1.500 | 9.65 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.120 | 1.000 | 9.51 | 0 | [0.1 - 0.5] |
Total Score | 5.83 |
Luminex Corporation
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators